Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism?

MLA

Glauber M. Leitão, et al. “Evaluating the Impact of Missenses Mutations in CYP2D6*7 and CYP2D6*14A: Does It Compromise Tamoxifen Metabolism?” Pharmacogenomics, vol. 17, Apr. 2016, pp. 561–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....446f40b32c0a27772c7d3226a9103531&authtype=sso&custid=ns315887.

APA

Glauber M. Leitão, Danyelly Bg Martins, Renato P Melo-Neto, José L. Lima-Filho, Carlos Hm Castelletti, & Maria Acsm Borba. (2016). Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism? Pharmacogenomics, 17, 561–570.

Chicago

Glauber M. Leitão, Danyelly Bg Martins, Renato P Melo-Neto, José L. Lima-Filho, Carlos Hm Castelletti, and Maria Acsm Borba. 2016. “Evaluating the Impact of Missenses Mutations in CYP2D6*7 and CYP2D6*14A: Does It Compromise Tamoxifen Metabolism?” Pharmacogenomics 17 (April): 561–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....446f40b32c0a27772c7d3226a9103531&authtype=sso&custid=ns315887.